Click here to get full coverage on With PRAxSCHOOLS initiative, K-12 students get up close and personal with artists, musicians - OSU Today

With PRAxSCHOOLS initiative, K-12 students get up close and personal with artists, musicians  OSU Today

With PRAxSCHOOLS initiative, K-12 students get up close and personal with artists, musicians - OSU Today

Click here to get full coverage on Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Essential3 Trial Results - simplywall.st

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Essential3 Trial Results  simplywall.st

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Essential3 Trial Results - simplywall.st

Click here to get full coverage on Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - Yahoo Finance

Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating  Yahoo Finance

Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down - Here's Why - MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down - Here's Why  MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down - Here's Why - MarketBeat

Click here to get full coverage on Can PRAX stock resist sector downturns - July 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com

Can PRAX stock resist sector downturns - July 2025 Weekly Recap & Fast Entry High Yield Stock Tips  newser.com

Can PRAX stock resist sector downturns - July 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com

Click here to get full coverage on Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $250 - 富途牛牛

Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $250  富途牛牛

Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $250 - 富途牛牛

Click here to get full coverage on Praxis (NASDAQ: PRAX) Q4 2025 interim may back 2026 relutrigine NDA in SCN2A & SCN8A - Stock Titan

Praxis (NASDAQ: PRAX) Q4 2025 interim may back 2026 relutrigine NDA in SCN2A & SCN8A  Stock Titan

Praxis (NASDAQ: PRAX) Q4 2025 interim may back 2026 relutrigine NDA in SCN2A & SCN8A - Stock Titan

Click here to get full coverage on PRAX Secures FDA Alignment on Relutrigine Program - GuruFocus

PRAX Secures FDA Alignment on Relutrigine Program  GuruFocus

PRAX Secures FDA Alignment on Relutrigine Program - GuruFocus

Click here to get full coverage on Noteworthy Monday Option Activity: PACS, PRAX, DASH - Nasdaq

Noteworthy Monday Option Activity: PACS, PRAX, DASH  Nasdaq

Noteworthy Monday Option Activity: PACS, PRAX, DASH - Nasdaq

Click here to get full coverage on Real time social sentiment graph for PRAX - Market Growth Report & Daily Volume Surge Signals - newser.com

Real time social sentiment graph for PRAX - Market Growth Report & Daily Volume Surge Signals  newser.com

Real time social sentiment graph for PRAX - Market Growth Report & Daily Volume Surge Signals - newser.com

Click here to get full coverage on OSU’s Día de los muertos ofrenda open to the public Nov. 2-4 at PRAx - OSU Today

OSU’s Día de los muertos ofrenda open to the public Nov. 2-4 at PRAx  OSU Today

OSU’s Día de los muertos ofrenda open to the public Nov. 2-4 at PRAx - OSU Today

Click here to get full coverage on Predicting PRAX trend using moving averages - Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com

Predicting PRAX trend using moving averages - Portfolio Value Summary & Growth Focused Stock Pick Reports  newser.com

Predicting PRAX trend using moving averages - Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com

Click here to get full coverage on Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy?  Yahoo Finance

Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Click here to get full coverage on Heatmap analysis for PRAX and competitors - Wall Street Watch & Accurate Entry/Exit Alerts - newser.com

Heatmap analysis for PRAX and competitors - Wall Street Watch & Accurate Entry/Exit Alerts  newser.com

Heatmap analysis for PRAX and competitors - Wall Street Watch & Accurate Entry/Exit Alerts - newser.com

Click here to get full coverage on Heatmap analysis for PRAX and competitors - 2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Heatmap analysis for PRAX and competitors - 2025 Risk Factors & Low Risk High Reward Ideas  newser.com

Heatmap analysis for PRAX and competitors - 2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Click here to get full coverage on Praxis Precision (PRAX) Triples on Stellar Drug Trial Results - Yahoo Finance

Praxis Precision (PRAX) Triples on Stellar Drug Trial Results  Yahoo Finance

Praxis Precision (PRAX) Triples on Stellar Drug Trial Results - Yahoo Finance

Click here to get full coverage on Using R and stats models for PRAX forecasting - July 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Using R and stats models for PRAX forecasting - July 2025 Catalysts & Reliable Entry Point Trade Alerts  newser.com

Using R and stats models for PRAX forecasting - July 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Click here to get full coverage on $PRAX stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

$PRAX stock is down 9% today. Here's what we see in our data.  Quiver Quantitative

$PRAX stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Prax Lindsey Oil Refinery Closure: Timeline and Key Dates - Energy Voice

Prax Lindsey Oil Refinery Closure: Timeline and Key Dates  Energy Voice

Prax Lindsey Oil Refinery Closure: Timeline and Key Dates - Energy Voice

Click here to get full coverage on Full technical analysis of PRAX stock - July 2025 Rallies & Detailed Earnings Play Strategies - newser.com

Full technical analysis of PRAX stock - July 2025 Rallies & Detailed Earnings Play Strategies  newser.com

Full technical analysis of PRAX stock - July 2025 Rallies & Detailed Earnings Play Strategies - newser.com

Click here to get full coverage on New Analyst Forecast: $PRAX Given $300.0 Price Target - Quiver Quantitative

New Analyst Forecast: $PRAX Given $300.0 Price Target  Quiver Quantitative

New Analyst Forecast: $PRAX Given $300.0 Price Target - Quiver Quantitative

Click here to get full coverage on UK court freezes £150m of assets of collapsed Prax Lindsey oil refinery owner - The Guardian

UK court freezes £150m of assets of collapsed Prax Lindsey oil refinery owner  The Guardian

UK court freezes £150m of assets of collapsed Prax Lindsey oil refinery owner - The Guardian

Click here to get full coverage on Is PRAX stock bottoming out - 2025 Retail Activity & Stepwise Trade Signal Implementation - newser.com

Is PRAX stock bottoming out - 2025 Retail Activity & Stepwise Trade Signal Implementation  newser.com

Is PRAX stock bottoming out - 2025 Retail Activity & Stepwise Trade Signal Implementation - newser.com

Click here to get full coverage on Serica Energy to Acquire Prax Upstream, Upcoming Asset Acquisitions - Rigzone

Serica Energy to Acquire Prax Upstream, Upcoming Asset Acquisitions  Rigzone

Serica Energy to Acquire Prax Upstream, Upcoming Asset Acquisitions - Rigzone

Click here to get full coverage on Heatmap analysis for PRAX and competitors - Dip Buying & Low Drawdown Trading Techniques - newser.com

Heatmap analysis for PRAX and competitors - Dip Buying & Low Drawdown Trading Techniques  newser.com

Heatmap analysis for PRAX and competitors - Dip Buying & Low Drawdown Trading Techniques - newser.com

Click here to get full coverage on Wedbush Maintains Praxis Precision Medicines (PRAX) Underperform Recommendation - Nasdaq

Wedbush Maintains Praxis Precision Medicines (PRAX) Underperform Recommendation  Nasdaq

Wedbush Maintains Praxis Precision Medicines (PRAX) Underperform Recommendation - Nasdaq

Click here to get full coverage on Praxis stock surges on late-stage trial win (PRAX:NASDAQ) - Seeking Alpha

Praxis stock surges on late-stage trial win (PRAX:NASDAQ)  Seeking Alpha

Praxis stock surges on late-stage trial win (PRAX:NASDAQ) - Seeking Alpha

Click here to get full coverage on Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains? - Nasdaq

Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains?  Nasdaq

Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains? - Nasdaq

Click here to get full coverage on Predicting PRAX trend using moving averages - Quarterly Earnings Report & Expert Curated Trade Ideas - newser.com

Predicting PRAX trend using moving averages - Quarterly Earnings Report & Expert Curated Trade Ideas  newser.com

Predicting PRAX trend using moving averages - Quarterly Earnings Report & Expert Curated Trade Ideas - newser.com

Click here to get full coverage on Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year High - Here's What Happened - MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year High - Here's What Happened  MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year High - Here's What Happened - MarketBeat

Click here to get full coverage on Brass Queens: 2025-26 PRAx Gala - visitcorvallis.com

Brass Queens: 2025-26 PRAx Gala  visitcorvallis.com

Brass Queens: 2025-26 PRAx Gala - visitcorvallis.com

Click here to get full coverage on Collapsed Prax has “large hole” in receivables facility, administrators say - Global Trade Review (GTR)

Collapsed Prax has “large hole” in receivables facility, administrators say  Global Trade Review (GTR)

Collapsed Prax has “large hole” in receivables facility, administrators say - Global Trade Review (GTR)

Click here to get full coverage on What’s Happening With Praxis Stock? - Trefis

What’s Happening With Praxis Stock?  Trefis

What’s Happening With Praxis Stock? - Trefis

Click here to get full coverage on Praxis Precision Medicines (PRAX) Is Up 256.7% After Positive Phase 3 Results for Essential Tremor Drug - simplywall.st

Praxis Precision Medicines (PRAX) Is Up 256.7% After Positive Phase 3 Results for Essential Tremor Drug  simplywall.st

Praxis Precision Medicines (PRAX) Is Up 256.7% After Positive Phase 3 Results for Essential Tremor Drug - simplywall.st

Click here to get full coverage on Why Is Praxis Precision Medicines (PRAX) Stock Up 155% Today? - TipRanks

Why Is Praxis Precision Medicines (PRAX) Stock Up 155% Today?  TipRanks

Why Is Praxis Precision Medicines (PRAX) Stock Up 155% Today? - TipRanks

Click here to get full coverage on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages  MarketBeat

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Assessing Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum - Yahoo Finance

Assessing Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum  Yahoo Finance

Assessing Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday  MarketBeat

Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Click here to get full coverage on 30‑Day option to buy up to 15% extra shares — Praxis Precision Medicines proposes public offering - Stock Titan

30‑Day option to buy up to 15% extra shares — Praxis Precision Medicines proposes public offering  Stock Titan

30‑Day option to buy up to 15% extra shares — Praxis Precision Medicines proposes public offering - Stock Titan

Click here to get full coverage on Praxis Precision Medicines (PRAX) Price Target Increased by 153.57% to 258.64 - Nasdaq

Praxis Precision Medicines (PRAX) Price Target Increased by 153.57% to 258.64  Nasdaq

Praxis Precision Medicines (PRAX) Price Target Increased by 153.57% to 258.64 - Nasdaq

Click here to get full coverage on University Day expands into PRAx parking lot to accommodate growing expo this year - OSU Today

University Day expands into PRAx parking lot to accommodate growing expo this year  OSU Today

University Day expands into PRAx parking lot to accommodate growing expo this year - OSU Today

Click here to get full coverage on Loan ‘irregularities’ led to collapse of Prax Lindsey oil refinery - The Guardian

Loan ‘irregularities’ led to collapse of Prax Lindsey oil refinery  The Guardian

Loan ‘irregularities’ led to collapse of Prax Lindsey oil refinery - The Guardian

Click here to get full coverage on $525M Offering — Praxis Precision Medicines Prices Common Stock at $157 per Share - Stock Titan

$525M Offering — Praxis Precision Medicines Prices Common Stock at $157 per Share  Stock Titan

$525M Offering — Praxis Precision Medicines Prices Common Stock at $157 per Share - Stock Titan

Click here to get full coverage on Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Phase 3 Results for Essential Tremor Drug - Sahm

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Phase 3 Results for Essential Tremor Drug  Sahm

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Phase 3 Results for Essential Tremor Drug - Sahm

Click here to get full coverage on Rapid Rise of PRAX: Essential Tremor Breakthrough - StocksToTrade

Rapid Rise of PRAX: Essential Tremor Breakthrough  StocksToTrade

Rapid Rise of PRAX: Essential Tremor Breakthrough - StocksToTrade

Click here to get full coverage on Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more - Seeking Alpha

Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more  Seeking Alpha

Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more - Seeking Alpha

Click here to get full coverage on Guggenheim Maintains Praxis Precision Medicines (PRAX) Buy Recommendation - Nasdaq

Guggenheim Maintains Praxis Precision Medicines (PRAX) Buy Recommendation  Nasdaq

Guggenheim Maintains Praxis Precision Medicines (PRAX) Buy Recommendation - Nasdaq

Click here to get full coverage on Red Baraat concert at PRAx gets employees on their feet and out of their heads - OSU Today

Red Baraat concert at PRAx gets employees on their feet and out of their heads  OSU Today

Red Baraat concert at PRAx gets employees on their feet and out of their heads - OSU Today

Click here to get full coverage on PRAx Presents: Harry Yeff, aka Reeps100 - visitcorvallis.com

PRAx Presents: Harry Yeff, aka Reeps100  visitcorvallis.com

PRAx Presents: Harry Yeff, aka Reeps100 - visitcorvallis.com

Click here to get full coverage on Insider Sale: 10% owner at $PRAX Sells 12,600 Shares - Quiver Quantitative

Insider Sale: 10% owner at $PRAX Sells 12,600 Shares  Quiver Quantitative

Insider Sale: 10% owner at $PRAX Sells 12,600 Shares - Quiver Quantitative

Click here to get full coverage on Ulixacaltamide Trial Success Propels PRAX - StocksToTrade

Ulixacaltamide Trial Success Propels PRAX  StocksToTrade

Ulixacaltamide Trial Success Propels PRAX - StocksToTrade

Click here to get full coverage on PRAx residencies provide varied opportunities for exploring intersections of art and science - OSU Today

PRAx residencies provide varied opportunities for exploring intersections of art and science  OSU Today

PRAx residencies provide varied opportunities for exploring intersections of art and science - OSU Today

Click here to get full coverage on We Are the League Feature Series: Meet Zach Prax - Minnesota State High School League

We Are the League Feature Series: Meet Zach Prax  Minnesota State High School League

We Are the League Feature Series: Meet Zach Prax - Minnesota State High School League

Click here to get full coverage on Praxis Shares Skyrocket: Too Late to Buy? - StocksToTrade

Praxis Shares Skyrocket: Too Late to Buy?  StocksToTrade

Praxis Shares Skyrocket: Too Late to Buy? - StocksToTrade

Click here to get full coverage on Noteworthy Thursday Option Activity: PRAX, MTN, ANF - Nasdaq

Noteworthy Thursday Option Activity: PRAX, MTN, ANF  Nasdaq

Noteworthy Thursday Option Activity: PRAX, MTN, ANF - Nasdaq

Click here to get full coverage on Prax Lindsey Oil Refinery 'unsafe' claims dismissed - BBC

Prax Lindsey Oil Refinery 'unsafe' claims dismissed  BBC

Prax Lindsey Oil Refinery 'unsafe' claims dismissed - BBC

Click here to get full coverage on Will Praxis Precision’s Momentum Endure? - StocksToTrade

Will Praxis Precision’s Momentum Endure?  StocksToTrade

Will Praxis Precision’s Momentum Endure? - StocksToTrade

Click here to get full coverage on PRAx Presents: Jacob Jolliff Band - visitcorvallis.com

PRAx Presents: Jacob Jolliff Band  visitcorvallis.com

PRAx Presents: Jacob Jolliff Band - visitcorvallis.com

Click here to get full coverage on Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - simplywall.st

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)?  simplywall.st

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - simplywall.st

Click here to get full coverage on Almost a third of Prax Lindsey oil refinery workers to lose jobs - The Guardian

Almost a third of Prax Lindsey oil refinery workers to lose jobs  The Guardian

Almost a third of Prax Lindsey oil refinery workers to lose jobs - The Guardian

Click here to get full coverage on Prax And The School Of Visual Performing And Design Arts Presents: An Hour For The Ears - visitcorvallis.com

Prax And The School Of Visual Performing And Design Arts Presents: An Hour For The Ears  visitcorvallis.com

Prax And The School Of Visual Performing And Design Arts Presents: An Hour For The Ears - visitcorvallis.com

Click here to get full coverage on PRAx Presents: Andy Akiho Ensemble - visitcorvallis.com

PRAx Presents: Andy Akiho Ensemble  visitcorvallis.com

PRAx Presents: Andy Akiho Ensemble - visitcorvallis.com

Click here to get full coverage on PRAx and the School of Visual, Performing and Design Arts Present: Music à la Carte, featuring DTW Lite - visitcorvallis.com

PRAx and the School of Visual, Performing and Design Arts Present: Music à la Carte, featuring DTW Lite  visitcorvallis.com

PRAx and the School of Visual, Performing and Design Arts Present: Music à la Carte, featuring DTW Lite - visitcorvallis.com

Click here to get full coverage on Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)?  Sahm

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm

Click here to get full coverage on Unite the Union urges Lindsey Oil Refinery staff to be furloughed - BBC

Unite the Union urges Lindsey Oil Refinery staff to be furloughed  BBC

Unite the Union urges Lindsey Oil Refinery staff to be furloughed - BBC

Click here to get full coverage on PRAX Stock: Surge or Sputter? - timothysykes.com

PRAX Stock: Surge or Sputter?  timothysykes.com

PRAX Stock: Surge or Sputter? - timothysykes.com

Click here to get full coverage on Trend analysis for PRAX this week - Quarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com

Trend analysis for PRAX this week - Quarterly Earnings Report & Weekly Consistent Profit Watchlists  newser.com

PRAX

Price Chart

Key Statistics

Technicals

About PRAX

Latest News

With PRAxSCHOOLS initiative, K-12 students get up close and personal with artists, musicians - OSU Today

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Essential3 Trial Results - simplywall.st

Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers